Los Angeles, California 90095

  • Cardiovascular Disease Risk


This project is prompted by the urgent public health need to identify novel strategies to prevent and treat tobacco-related cardiovascular disease (CVD) and by compelling pilot data that suggests cessation of smoking results in rapid amelioration of endothelial function. The higher prevalence of CVD and metabolic syndrome in smokers have become major health care concerns. Therefore, finding optimal intervention strategies to combat these growing epidemics is imperative. We are investigating the efficacy of resistance training to ameliorate endothelial dysfunction, oxidative stress, inflammation, and insulin resistance in four groups: presence or absence of resistance training with or without cessation treatment + nicotine replacement. The investigators hypothesize that resistance training will improve cardiovascular function in smokers; however, the responses will be better in those who also stop smoking. In addition, resistance training will decrease smoking, however, the effects of counseling and nicotine replacement alone or counseling and nicotine replacement in conjunction with resistance training will be better than resistance training alone.

Study summary:

The investigators are conducting a 12-week randomized-controlled trial of 100 young adult smokers. At week 0, participants attend three outpatient visits at baseline. Each participant is randomized to one of four groups: Resistance Training(RT)/Nicotine Replacement Therapy (NRT), RT/No NRT, No RT/NRT, and No RT/No NRT. Those receiving RT work with a certified personal trainer 3 times per week for 12 weeks at 60 minutes each session. Those receiving NRT use the nicotine patch daily for 12 weeks and call the California Smoker's Helpline for smoking cessation counseling. Those in the control group do not receive any intervention and maintain their current lifestyle and habits. At week 13, participants return for three post-intervention assessments. At week 26, survey data is collected to assess changes in lifestyle habits.


Inclusion Criteria: - Young Adults (18-35 yrs.) - Male and female smokers - Smokers (smoked at least one cigarette a day for 15 or more days in the last month and has smoked 100 cigarettes in life) - 1-3 years experience consistently exercising/training at ≤2 days/wk of RT and ≤1 day/wk of aerobic exercise - Capable of providing informed consent - UCLA students/staff and Non UCLA student/staff - Participant in good health as determined by baseline visit Exclusion Criteria: - Documented CAD - Has had cardiac surgery - Currently in weight loss or exercise program in the 6 months prior to participation. - Use of medications that influence CV function or preclude the ability to train - Syndromes or prescribed medications that may influence CVD, body composition, or insulin action (e.g. prednisone, Ritalin, Adderall, GH) - Unable to exercise - Diagnosed with syndromes or diseases that may influence body composition and CV risk (e.g. Cushing syndrome). - Known heart arrhythmia and/or abnormalities found in electrocardiogram (ECG) reading that would prevent someone from performing the exercise intervention. If the subject demonstrates abnormal ECG during their pre-intervention visit (or any follow-up visit) the subject's ECG will be reviewed (for approval) by a cardiologist to continue in the study. - Pregnant - Use of hormonal contraceptives - Currently in a smoking cessation program including use of NRT within the month of participation



Primary Contact:

Principal Investigator
Christian K Roberts, Ph.D
University of California, Los Angeles

Exercise and Metabolic Disease Laboratory
Email: info@uclaemdr.com

Backup Contact:


Location Contact:

Los Angeles, California 90095
United States

There is no listed contact information for this specific location.

Site Status: Recruiting

Data Source: ClinicalTrials.gov

Date Processed: September 27, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.